Home-based heart check using single-lead ECG

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter observational project will enroll adults at five hospitals in Taiwan who have a compatible single-lead ECG (Apple Watch or QOCA ECG102D) and a transthoracic echocardiogram performed within 30 days. The AI-ECG model's predictions from the single-lead recordings will be compared to echocardiographic reference standards for left ventricular ejection fraction and other structural phenotypes. Participants will be recruited between March 1 and June 30, 2026, and recordings with insufficient signal quality or without timely echocardiography will be excluded. The goal is to validate model accuracy in a real-world, home-based outpatient setting across multiple centers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 20 years or older
* Single-lead ECG recorded using a study-compatible device
* Ability to comply with study procedures and, when applicable, provide informed consent according to local institutional review board (IRB) requirements
* No transthoracic echocardiography performed within 90 days before the index ECG

Exclusion Criteria:

* ECG signal quality insufficient for prespecified AI analysis
* No transthoracic echocardiography available within 30 days after the index ECG
* Echocardiography unavailable or technically inadequate for determining left ventricular ejection fraction (EF)

Where it's running

• Taipei Medical University WanFang Hospital; Far Eastern Memorial Hospital; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Chi Mei Medical Hospital; and China Medical University Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: CHIN LIN, PhD — National Defense Medical Center
• Study coordinator: CHIN LIN, PhD
• Email: xup6fup0629@gmail.com
• Phone: +886958259269

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• NT-proBNP–guided heart failure screening for people 65+ in rural China

  This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.

  Recruiting Jiangsu Taizhou People's Hospital · Nanjing · NCT07885488

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.